C04AD04 ( WHO ) 2-(1,3-Dimethyl-2,6-dioxopurin-7-yl)ethyl pyridine-3-carboxylate Interactive image Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCOC(=O)c3cccnc3 InChI=1S/C15H15N5O4/c1-18-12-11(13(21)19(2)15(18)23)20(9-17-12)6-7-24-14(22)10-4-3-5-16-8-10/h3-5,8-9H,6-7H2,1-2H3 Key:ZWIAODBBEZGVPY-UHFFFAOYSA-N Etofylline nicotinate is a vasodilator . [ 1 ] ↑ Vilar S, Quezada E, Alcaide C, Orallo F, Santana L, Uriarte E (9 March 2007). "Quantitative Structure Vasodilatory Activity Relationship – Synthesis and "In Silico" and "In Vitro" Evaluation of Resveratrol-Coumarin Hybrids". QSAR & Combinatorial Science . 26 (3): 317– 332. doi : 10.1002/qsar.200630006 . Non-selective Buflomedil Phentolamine Phenoxybenzamine Tolazoline Phenoxybenzamine Selective α 1 -blockers Alfuzosin Doxazosin Prazosin Silodosin Tamsulosin Terazosin Nicotinyl alcohol Inositol nicotinate Xantinol nicotinate

Etofylline nicotinate Dihydroergocristine This drug article relating to the cardiovascular system is a stub . You can help Wikipedia by adding missing information . Nicotinate esters Cardiovascular system drug stubs Articles with short description Short description matches Wikidata Short description is different from Wikidata ECHA InfoCard ID from Wikidata Articles without EBI source Chemical pages without DrugBank identifier Articles without KEGG source Drugs with no legal status Drugboxes which contain changes to watched fields All stub articles